Grantham, Mayo, Van Otterloo & Co (GMO)’s PDL BioPharma, Inc. PDLI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-980,800	Closed	-$3.09M	–	921
2020 Q3	$3.09M	Sell	980,800 -127,100	-11%	-$406K	0.02%	326
2020 Q2	$3.22M	Buy	1,107,900 +113,600	+11%	+$359K	0.02%	324
2020 Q1	$2.8M	Sell	994,300 -137,700	-12%	-$444K	0.02%	339
2019 Q4	$3.67M	Sell	1,132,000 -197,600	-15%	-$574K	0.02%	327
2019 Q3	$2.87M	Sell	1,329,600 -349,300	-21%	-$934K	0.02%	369
2019 Q2	$5.27M	Sell	1,678,900 -4,900	-0.3%	-$15.9K	0.04%	282
2019 Q1	$6.26M	Buy	+1,683,800	New	+$5.68M	0.05%	232
2017 Q2	–	Sell	-63,997	Closed	-$145K	–	673
2017 Q1	$145K	Sell	63,997 -1,006,512	-94%	-$2.23M	﹤0.01%	556
2016 Q4	$2.27M	Sell	1,070,509 -1,224,725	-53%	-$3.42M	0.01%	305
2016 Q3	$7.69M	Sell	2,295,234 -557,868	-20%	-$1.77M	0.04%	225
2016 Q2	$8.96M	Buy	2,853,102 +395,987	+16%	+$1.32M	0.04%	239
2016 Q1	$8.18M	Buy	2,457,115 +2,260,415	+1,149%	+$7.05M	0.03%	253
2015 Q4	$696K	Sell	196,700 -2,300	-1%	-$9.63K	﹤0.01%	418
2015 Q3	$1M	Buy	+199,000	New	+$1.14M	﹤0.01%	403
2014 Q1	–	Sell	-42,543	Closed	-$359K	–	725
2013 Q4	$359K	Sell	42,543 -5,064	-11%	-$42.7K	﹤0.01%	603
2013 Q3	$379K	Sell	47,607 -9,326	-16%	-$75K	﹤0.01%	594
2013 Q2	$440K	Buy	+56,933	New	+$444K	﹤0.01%	551

Other funds holding PDLI